ARTICLE | Clinical News
Intuniv guanfacine extended release regulatory update
August 3, 2009 7:00 AM UTC
FDA issued a complete response letter for Intuniv guanfacine extended release to treat ADHD in children and adolescents ages 6-17. Shire said it was unable to agree with the agency on product labeling...